Value-based drug reimbursement: Introduction to the main features of the german pharmaceutical policy
Sep 29, 2015
Presentado por:
Dr. Wolfgang Greiner
In this CRITERIA webinar, our guest, Dr. Wolfgang Greiner, delves into drug price regulation based on additional therapeutic value and the role of cost-benefit evaluations, based on the experience of Germany, after the reforms implemented in 2011.
Archivos adicionales
Artículos recomendados